2024 Onco-Nephrology Symposium — On Demand

Friday, October 18, 2024, 8:00 AM - Thursday, July 31, 2025, 11:00 PM

We're pleased to present an on-demand option for the 2024 Onco-Nephrology Symposium, originally held live on September 13-14, 2024. This program is designed for the entire healthcare team managing patients with both cancer and kidney disease, offering a comprehensive look at the multidisciplinary nature of onco-nephrology.

Leading experts in plasma cell disorders—including multiple myeloma, amyloidosis, and monoclonal gammopathies—along with distinguished speakers on CAR T cell and other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes, present a comprehensive array of topics at the intersection of cancer and kidney disease. For further information about this program and session topics, view the brochure from the live course.

1. Outline a comprehensive assessment and treatment of thrombotic microangiopathy
2. Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
3. Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
4. Recognize renal and non-renal toxicities of modern cancer therapy
5. Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
6. Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
7. Review assessment and management of glomerular disorders in cancer patients
8. Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney

Upon successful registration, access to the course materials, including instructions for claiming credit, are located under the 'Course Content' tab. This on demand program will be available for purchase until April 30, 2025 For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through July 31, 2025.

On Demand Access Fees
Physicians (MDs, PhDs, and DOs): $450
Advanced Practice Providers: $350
Residents, Fellows, Nurses, and Other Healthcare Providers: $250
MSK Employees: Complimentary

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

11.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
11.00 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit. MOC points will be awarded approximately 45 days after the submission of your evaluation.

Recorded/Review Date: September 13-14, 2024 | Original Release Date: October 18, 2024 | Termination Date: July 31, 2025

 

MSK Course Directors 

Sheron Latcha, MD
Program Director, Nephrology Fellowship;
Attending, Renal Service, 
Department of Medicine 

Aisha Shaikh, MBBS
Associate Attending, Renal Service 
Department of Medicine 

 

Invited Symposium Faculty 

Ala Abudayyeh, MD
Director, of Clinical Research, Division Section of Nephrology
MD Anderson Cancer Center
Houston, TX, USA

Pooja Amarapurkar MD 
Director of Onco-Nephrology;
Assistant Professor of Medicine, 
Renal and Electrolyte Division 
University of Pittsburgh School of Medicine 
University of Pittsburgh Medical Center 
Pittsburgh, PA, USA

Chris Blosser, MD
Professor of Medicine; 
Director, Fred Hutch Cancer and Organ Transplant Clinic;
Director, Center for Innovations in Cancer and Transplant,
University of Washington; 
Seattle Children’s Hospital;
Fred Hutch Cancer Center
Seattle, Washington, USA

Sandra Herrmann, MD
Professor of Medicine 
Mayo Clinic
Rochester, MN, USA

Kenar Jhaveri, MD 
Professor of Medicine;
Co-Director Onco-Nephrology Services
Donald and  Barbara Zucker School of Medicine at Hofstra / Northwell 
New York, NY, USA

Sabine Karam, MD 
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN, USA

David Kavanagh, PhD
Professor of Complement Therapeutic at National Renal Complement Therapeutics Centre,
Freeman Hospital Renal Center
Newcastle Upon Tyne, England, UK

Abhijat Kitchlu MD, MSc
Staff Nephrologist; Clinician Investigator,
University Health Network;
Associate Professor of Medicine,
University of Toronto
Toronto, ON, Canada

Nelson Leung, MD
Professor of Medicine; 
Program Director, Onco-Nephrology Fellowship
Mayo Clinic
Rochester, MN, USA

Syed Saad Mahmood, MD, MPH
System Director, Cardio-Oncology 
St. Francis Hospital & Heart Center 
Roslyn, NY, USA

Glen Markowitz, MD
Professor of Pathology and Cell Biology;
Executive Vice Chair for Anatomic Pathology
Columbia University Irving Medical Center
New York, NY, USA

Samih Nasr, MD
Professor of Laboratory Medicine and Pathology 
Mayo Clinic
Rochester, MN, USA

Carla Nester, MD, MSA, FASN
Associate Director, Molecular Otolaryngology and Renal Research Laboratories;
Director, Pediatric Glomerular Disease Clinic;
Director, Rare Disease Clinic 
University of Iowa Hospitals and Clinics
Iowa City, IA, USA

Arash Rashidi, MD
Clinical Associate Professor; 
Director, Onco-Nephrology Program
University Hospitals Cleveland Medical Center
Cleveland, OH, USA

Steven Salvatore, MD
Associate Professor of Clinical Pathology and Laboratory Medicine 
Weill Cornell Medicine
New York, NY, USA

Biruh Workaneh, MD
Professor of Medicine
MD Anderson Cancer Center
Houston, TX, USA

 

MSK Symposium Faculty

Lisa Bodei, MD, PhD
Director, Radiopharmaceutical Therapy Section; 
Attending, Molecular Imaging and Therapy Service,
Department of Radiology

Jessica Chapman, PhD
Director, Clinical Proteomics;
Assistant Attending, Hematopathology Service,
Department of  Pathology and Laboratory Medicine

Sherrilyn Eudoxie, RN
Clinical Nurse

James Flory, MD
Associate Attending, Endocrinology Service,
Department of Medicine;
Associate Professor of Medicine

Samuel Funt, MD
Assistant Attending, Genitoruinary Oncology Service,
Department of Medicine;
Assistant Professor of Medicine 

Ilya Glezerman, MD
Attending; Clinical Director, Renal Service
Department of Medicine 

Victoria Gutgarts, MD
Assistant Attending, Renal Service,
Department of Medicine;
Assistant Professor of Medicine

Ari Hakimi, MD
Associate Attending, Urology Service,
Department of Surgery; 
Associate Professor of Surgery

Hamza Hashimi, MD
Assistant Attending, Myeloma Service,
Department of Medicine

Hani Hassoun, MD
Attending, Myeloma Service,
Department of Medicine;
Professor of Medicine

Malin Hulcrantz, MD
Associate Attending, Myeloma Service,
Department of Medicine;
Associate Professor of Medicine

Insara Jaffer Sathick, MBBS
Assistant Attending, Renal Service,
Department of Medicine;
Assistant Professor of Medicine

Edgar Jaimes, MD
Chief, Renal Service,
Department of Medicine;
Professor of Medicine

Heather Landau, MD
Director, Amyloidosis Program; 
Associate Attending, Bone Marrow Transplant and Cellular Therapy Services,
Department of Medicine

Jennifer Liu, MD, FACC
Chief, Cardiology Service;
Director Cardiovascular Laboratories
Department of Medicine

Monica Maguire, RN
Clinical Nurse

Sham Mailankody, MBBS
Associate Attending; Clinical Director, Cellular Therapy Service; 
Research Director, Myeloma Service,
Department of Medicine
Associate Professor of Medicine

Kazunori Murata, PhD
Director, Ralph Lauren Center Laboratory

Karlo Perica, MD
Assistant Attending, Immunology Program,
Sloan Kettering Institute;
Assistant Professor of Medicine

Michael Scordo, MD
Assistant Attending, Bone Marrow Transplant and Cellular Therapy Services, 
Department of Medicine 

Saad Usmani, MD
Chief, Myeloma Service,
Department of Medicine 

Martin Voss, MD
Associate Attending; Clinical Director, 
Genitourinary Medical Oncology Service,
Department of Medicine;
Associate Professor of Medicine

 

View relevant financial relationships as of the program dates, September 13—14, 2024. 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.